The German Electron Synchrotron (German: Deutsche Elektronen-Synchrotron), abbreviated DESY, is a national research center in Germany which operates particle accelerators used to investigate the structure of matter. It conducts a broad spectrum of inter-disciplinary scientific research in three main areas: particle and high energy physics; photon science; and the development, construction and operation of particle accelerators. The DESY is publicly financed by the Federal Republic of Germany, the States of Germany, and the German Research Foundation (DFR). DESY is a member of the Helmholtz Association and operates at sites in Hamburg and Zeuthen. DESY's function is to conduct fundamental research. It specializes in: In addition to operating its own large accelerator facilities, DESY also provides consulting services to research initiatives, institutes and universities. It is closely involved in major international projects such as the European X-Ray Free-Electron Laser, the Large Hadron Collider in Geneva, the IceCube Neutrino Observatory at the South Pole and the International Linear Collider.

Website
http://en.wikipedia.org/wiki/index.html?curid=53297
Wikipedia
http://en.wikipedia.org/wiki/German_Electron_Synchrotron

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Sixty-year-old question on DNA replication timing sequence answered

Over the last 60 years, scientists have been able to observe how and when genetic information was replicated, determining the existence a "replication timing program," a process that controls when and in what order segments ...

Perovskites under pressure: Hot electrons cool faster

In solar cells, about two third of the energy of sunlight is lost. Half of this loss is due to a process called 'hot carrier cooling' where high energy photons lose their excess energy in the form of heat before being converted ...

Research shows pain relieving effects of CBD

It's been hailed as a wonder drug and it's certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could be worth $20 billion dollars by 2024. While users tout its effectiveness in pain relief, ...

Claim rates ID'd for musculoskeletal disorders from overexertion

(HealthDay)—The rate of work-related musculoskeletal disorder (WMSD) claims from overexertion among construction workers is highest for those aged 35 to 44 years, although the severity of WMSDs increases with age, according ...

Few SARS-CoV-2 vaccine breakthrough infections reported at SNFs

(HealthDay)—Few cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have been reported at skilled nursing facilities (SNFs) among those with at least 14 days since receipt of the second dose ...